Local control and survival after stereotactic body radiation therapy of early-stage lung cancer patients in Slovenia

Abstract

Stereotactic body radiation therapy (SBRT) precisely and non-invasively delivers ablative radiation dose to tumors in early-stage lung cancer patients who are not candidates for surgery or refuse it. The aim of research was to evaluate local control, overall survival (OS), local progression free survival (LPFS), distant metastases free survival (DMFS), disease free survival (DFS) and toxicity in early-stage lung cancer patients treated with SBRT in a single tertiary cancer centre.

Keywords

• stereotactic body radiotherapy (sbrt)
• early-stage lung cancer
• lung cancer
• local control
• survival